Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2026-04-19 @ 7:12 AM
Study NCT ID:
NCT05428033
Status:
COMPLETED
Last Update Posted:
2025-07-22
First Post:
2022-06-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD)
Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
405-201-00021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None